Medical specialists from France tagged as investigators in clinical trials studying Lymphoma, Large B-Cell, Diffuse
Total 87 results
-
ABRAHAM Julie, MDSeen in:
- Limoges, CHU Limoges
Trials:- NCT04446962 (Principal Investigator)
-
Adrian TempesculSeen in:
- Other, Brest Cedex, Centre Hospitalier Regional Universitaire (CHRU) Brest - Hopital Morvan
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Adrien CHAUCHETSeen in:
- Besançon, CHU Besançon
- Besançon, CHU Jean Minjoz
Trials:- NCT04670029 (Principal Investigator)
- NCT04446962 (Principal Investigator)
-
Agathe Waultier-Rascalou, MDSeen in:
- Nîmes, CHU Nîmes - Carémeau
- Nîmes, CHU de Nîmes - Hôpital Caremeau
Trials:- NCT04446962 (Principal Investigator)
- NCT05529524 (Principal Investigator)
-
Anna SCHMITT, MDSeen in:
- Bordeaux, Institut Bergonie
Trials:- NCT04446962 (Principal Investigator)
-
Antoine ItalianoSeen in:
- Aquitaine, Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, Bergonie Institute
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05009927 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT05440786 (Principal Investigator)
- NCT05269355 (Principal Investigator)
- NCT02834884 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT02029001 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT05920408 (Principal Investigator)
- NCT05999994 (Principal Investigator)
Conditions:- C-KIT Mutation;
- Metastatic Gastrointestinal Stromal Tumor (GIST);
- Advanced Gastrointestinal Stromal Tumor (GIST);
- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Neoplasm Metastasis;
- Sarcoma, Ewing;
- Leiomyosarcoma;
- All Tumor Types;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor;
- Malignant Solid Neoplasms;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Advanced Solid Tumours;
- Adolescent;
- Neoplasms;
- Child
-
Bertrand JolySeen in:
- Other, Corbeil-Essonnes, Centre Hospitalier Sud Francilien
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Bertrand SARDINSeen in:
- Limoges, CHU Limoges
Trials:- NCT03800095 (Sub-Investigator)
-
Carole Soussain, MDSeen in:
- Paris, Institut Curie
Trials:- NCT04446962 (Principal Investigator)
-
Caroline DELETTE, MDSeen in:
- Amiens, CHU Amiens
Trials:- NCT04446962 (Principal Investigator)
-
Caroline HOUILLIER, MDSeen in:
- Paris, CHU Pitié-Salpêtrière
- Paris, Hôpital Pitié-Salpétrière
Trials:- NCT04446962 (Principal Investigator)
- NCT05135858 (Principal Investigator)
-
Caroline Serrier, MDSeen in:
- Other, Perpignan CEDEX, Centre Hospitalier de Perpignan
Trials:- NCT04404283 (Principal Investigator)
Conditions: -
Catherine RIOUFOL, Pharm DSeen in:
- Pierre-Bénite, Hospices Civils de Lyon -Groupement Hospitalier Sud Service pharmaceutique, Unité de Pharmacie Clinique Oncologique
- Pierre-Bénite, Service pharmaceutique, Hospices Civils de Lyon - Groupement Hospitalier Sud
Trials:- NCT05532761 (Principal Investigator)
- NCT04914091 (Principal Investigator)
-
Catherine THIEBLEMONT, MD PhDSeen in:
- Paris, Hôpital Saint louis
Trials:- NCT04703686 (Principal Investigator)
-
Cécile MOLUCON-CHABROT, MDSeen in:
- Clermont-Ferrand, Chu Clermont-Ferrand
- Clermont-Ferrand, Service d'hématologie - Hôpital Gabriel Montpied
Trials:- NCT04446962 (Principal Investigator)
- NCT03354936 (Principal Investigator)
-
Cyril AbdeddaimSeen in:
- Lille, Centre OSCAR LAMBRET
- Lille, Oscar Lambret Center
Trials:- NCT03088059 (Principal Investigator)
- NCT04104776 (Principal Investigator)
-
Elsa LESTANG, MDSeen in:
- Saint-Nazaire, CH Saint Nazaire
- Saint-Nazaire, Centre Hospitalier de St Nazaire
Trials:- NCT05298293 (Principal Investigator)
- NCT03223961 (Principal Investigator)
Conditions: -
Emmanuel GYAN, MDSeen in:
- Cedex 01, Tours, CHU de Tours - Hôpital Bretonneau
- Tours, CHU de Tours
- Tours, Chu Tours
- Tours, Tours University Hospital
Trials:- NCT05178849 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT04446962 (Principal Investigator)
- NCT02649790 (Principal Investigator)
- NCT05790733 (Principal Investigator)
Conditions:- Bone Marrow Biopsy;
- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary;
- Acute Myeloid Leukemia (AML);
- Metastatic Colorectal Cancer (mCRC);
- Metastatic Castration-Resistant Prostate Cancer (mCRPC);
- Relapsed/Refractory Multiple Myeloma (RRMM);
- Higher-Risk Myelodysplastic Syndrome (HR-MDS);
- Newly Diagnosed Intermediate/High-Risk MDS;
- Chemotherapy Effect;
- Aplasia
-
Fabien Le Bras, MDSeen in:
- Créteil, Hôpital Henri Mondor
Trials:- NCT04703686 (Principal Investigator)
-
Fabrice JARDIN, PhDSeen in:
- Rouen, Centre Henri Becquerel
Trials:- NCT04446962 (Principal Investigator)
-
Fontanet BijouSeen in:
- Aquitaine, Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
- Other, Bordeaux, Centre de Lutte Contre le Cancer (CLCC) - Institut Bergonie
Trials:- NCT04662255 (Principal Investigator)
- NCT04404283 (Principal Investigator)
Conditions: -
Franck DELPRETTISeen in:
- Vichy, CH Jacques Lacarin
Trials:- NCT03800095 (Sub-Investigator)
-
Franck MORSCHHAUSER, MD PhDSeen in:
- Lille, CHRU LILLE - Hôpital Claude Huriez
- Lille, CHRU Lille
- Lille, Service des Maladies du Sang - CHRU de Lille
Trials:- NCT04703686 (Principal Investigator)
- NCT04446962 (Principal Investigator)
- NCT04842877 (Principal Investigator)
Conditions:- Refractory Indolent Adult Non-Hodgkin Lymphoma;
- Refractory Mantle Cell Lymphoma;
- Diffuse Large B-Cell Lymphoma Refractory;
- Refractory Transformed B-cell Non-Hodgkin Lymphoma;
- Refractory Primary Mediastinal Large B-Cell Cell Lymphoma;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary;
- Lymphoma, B-Cell
-
François X Gros, MDSeen in:
- Pessac, Chu de Bordeaux - Hopital Haut Leveque
Trials:- NCT04703686 (Principal Investigator)
-
Frédéric MALOISEL, MDSeen in:
- Strasbourg, Centre de radiothérapie de Robertsau
Trials:- NCT05298293 (Principal Investigator)
Conditions: -
Frédéric PEYRADE, MDSeen in:
- Nice, Centre Lacassagne
- Other, Nice Cedex 2, Centre de Lutte contre le Cancer (CLCC) - Centre Antoine Lacassagne
Trials:- NCT04404283 (Principal Investigator)
- NCT04446962 (Principal Investigator)
-
Gandhi DAMAJ, PhDSeen in:
- Caen, CHU caen
Trials:- NCT04446962 (Principal Investigator)
Clinical Trials on Lymphoma, Large B-Cell, Diffuse
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | DLBCL - Diffuse Large B Cell Lymphoma | Large B-cell Lymphoma | Large-cell Lymphoma | Mediastinal B-Cell Diffuse Large Cell LymphomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); AmgenActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 Positive | Stage I Diffuse Large B-Cell Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell LymphomaUnited States
-
Qian WenbinNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaChina
-
University Hospital Southampton NHS Foundation...Hoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited Kingdom
-
National Cancer Institute (NCI)WithdrawnDiffuse, Large B-cell Lymphoma | Lymphoma, Diffuse Large-Cell | Lymphoma, Diffuse Large-Cell B-cell | Large-Cell Lymphoma, Diffuse
-
Dana-Farber Cancer InstituteBayer; AbbVieActive, not recruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterSanofi; Columbia University; Medical College of Wisconsin; University of Rochester and other collaboratorsActive, not recruitingDiffuse Large B-cell Lymphoma (DLBCL) | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)United States
-
Autolus LimitedCompletedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | DLBCL | Relapsed Diffuse Large B-Cell LymphomaUnited States, United Kingdom
-
Herlev HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma | Diffuse Large B-Cell Lymphoma Cell of Origin
-
UNC Lineberger Comprehensive Cancer CenterCephalonCompletedLymphoma | Diffuse Large B-Cell Lymphoma | Lymphoma, Diffuse Large-Cell | Diffuse Large-Cell LymphomaUnited States